PDE5-Inhibition With Sildenafil in Chronic Heart Failure
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
To test the hypothesis that long-term PDE5-inhibition by overexpressing the nitric oxide
pathway is beneficial in chronic heart failure patients.
Double-blind and placebo-controlled trial. Primary end-points: quality of life and exercise
performance